| Dr Mitchell G Kirsch, MD | |
|
2500 Route 347 Bldg 14a, Stony Brook, NY 11790-2554 | |
| (631) 689-7800 | |
| (631) 689-3016 |
| Full Name | Dr Mitchell G Kirsch |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 43 Years |
| Location | 2500 Route 347 Bldg 14a, Stony Brook, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184621500 | NPI | - | NPPES |
| 1319 | Other | NY | VYTRA |
| 00947026 | Medicaid | NY | |
| 390001251 | Other | NY | MEDICARE RAILROAD |
| 69D221 | Other | NY | EMPIRE BLUECROSS BLUESHIE |
| CS664 | Other | NY | OXFORD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 157097 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Huntington Akc- Medford Ext. | Medford, NY | Dialysis facility |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Shore Hematology Oncology Associates Pc | 1456243641 | 314 |
News Archive
A researcher from Vrije Universiteit Amsterdam, The Netherlands, and a tropical medicine expert who lives in Wamena, Indonesia have published a unique account of a village in the Papuan highlands of Indonesia that has experienced what was presumed to be an outbreak of coronavirus disease 2019 (COVID-19)
Galectin Therapeutics Inc. today announced that the European Patent Office has granted the Company a new patent, No. 02731178.6, "Co-administration of a Polysaccharide with a Chemotherapy for the Treatment of Cancer".
Cellular Dynamics International (CDI) today announced that CDI's development and commercialization of human cardiomyocytes for drug discovery and toxicity testing, based on the work of CDI co-founder and chief scientific officer, James A. Thomson, Ph.D., on induced pluripotent stem cell (iPSCs) technology, have been named to the MIT Technology Review's Annual 10 Emerging Technologies List.
Oncotarget recently published "Neuroendocrine carcinoma of uterine cervix findings shown by MRI for staging and survival analysis – Japan multicenter study" which reported that to investigate neuroendocrine carcinoma of the uterine cervix cases for MRI features and staging, as well as pathological correlations and survival.
Spanish consumers are defenceless against deceptive advertising broadcasted on the radio in areas that could affect their health, according to a study carried out by two lecturers at the Rey Juan Carlos University in Madrid. The project reports that this infringement of law takes place specifically in health-related advertisements.
› Verified 4 days ago
| Entity Name | North Shore Hematology Oncology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396794574 PECOS PAC ID: 1456243641 Enrollment ID: O20040324001766 |
News Archive
A researcher from Vrije Universiteit Amsterdam, The Netherlands, and a tropical medicine expert who lives in Wamena, Indonesia have published a unique account of a village in the Papuan highlands of Indonesia that has experienced what was presumed to be an outbreak of coronavirus disease 2019 (COVID-19)
Galectin Therapeutics Inc. today announced that the European Patent Office has granted the Company a new patent, No. 02731178.6, "Co-administration of a Polysaccharide with a Chemotherapy for the Treatment of Cancer".
Cellular Dynamics International (CDI) today announced that CDI's development and commercialization of human cardiomyocytes for drug discovery and toxicity testing, based on the work of CDI co-founder and chief scientific officer, James A. Thomson, Ph.D., on induced pluripotent stem cell (iPSCs) technology, have been named to the MIT Technology Review's Annual 10 Emerging Technologies List.
Oncotarget recently published "Neuroendocrine carcinoma of uterine cervix findings shown by MRI for staging and survival analysis – Japan multicenter study" which reported that to investigate neuroendocrine carcinoma of the uterine cervix cases for MRI features and staging, as well as pathological correlations and survival.
Spanish consumers are defenceless against deceptive advertising broadcasted on the radio in areas that could affect their health, according to a study carried out by two lecturers at the Rey Juan Carlos University in Madrid. The project reports that this infringement of law takes place specifically in health-related advertisements.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mitchell G Kirsch, MD 1500 Route 112 Bldg 4, Port Jefferson Station, NY 11776-8055 Ph: (631) 751-3000 | Dr Mitchell G Kirsch, MD 2500 Route 347 Bldg 14a, Stony Brook, NY 11790-2554 Ph: (631) 689-7800 |
News Archive
A researcher from Vrije Universiteit Amsterdam, The Netherlands, and a tropical medicine expert who lives in Wamena, Indonesia have published a unique account of a village in the Papuan highlands of Indonesia that has experienced what was presumed to be an outbreak of coronavirus disease 2019 (COVID-19)
Galectin Therapeutics Inc. today announced that the European Patent Office has granted the Company a new patent, No. 02731178.6, "Co-administration of a Polysaccharide with a Chemotherapy for the Treatment of Cancer".
Cellular Dynamics International (CDI) today announced that CDI's development and commercialization of human cardiomyocytes for drug discovery and toxicity testing, based on the work of CDI co-founder and chief scientific officer, James A. Thomson, Ph.D., on induced pluripotent stem cell (iPSCs) technology, have been named to the MIT Technology Review's Annual 10 Emerging Technologies List.
Oncotarget recently published "Neuroendocrine carcinoma of uterine cervix findings shown by MRI for staging and survival analysis – Japan multicenter study" which reported that to investigate neuroendocrine carcinoma of the uterine cervix cases for MRI features and staging, as well as pathological correlations and survival.
Spanish consumers are defenceless against deceptive advertising broadcasted on the radio in areas that could affect their health, according to a study carried out by two lecturers at the Rey Juan Carlos University in Madrid. The project reports that this infringement of law takes place specifically in health-related advertisements.
› Verified 4 days ago
Mohamed Hassan Kamel, MD Nephrology Medicare: Medicare Enrolled Practice Location: Stony Brook University Hospital 101 Nicolls Road, Stony Brook, NY 11794 Phone: 631-689-8333 | |
Narinder Singh, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 101 Nicolls Rd, Stony Brook, NY 11794 Phone: 631-444-4000 | |
Dr. Andrzej Kudelka, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3 Pellegrino Rd, Z8151, Stony Brook, NY 11794 Phone: 631-638-0910 Fax: 631-638-0195 | |
Saverio J Barbera, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: Health Science Center Nicolls Road, T-16-080, Stony Brook, NY 11794 Phone: 631-444-3575 Fax: 631-444-1054 | |
Dr. Richard Lin, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: University Hospital, L5, Stony Brook, NY 11794 Phone: 631-444-2540 | |
Dr. Ajay Malhotra, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: Hsc L4 Rm 120, Stony Brook, NY 11794 Phone: 631-444-5400 Fax: 631-444-7538 | |
Dr. John Anthony Savino Iii, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1320 Stony Brook Rd Bldg D, Stony Brook, NY 11790 Phone: 212-241-1653 Fax: 212-289-6393 |